9 results on '"Eukaryotic translation initiation factor 2"'
Search Results
2. The third structural switch in the archaeal translation initiation factor 2 (aIF2) molecule and its possible role in the initiation of GTP hydrolysis and the removal of aIF2 from the ribosome.
- Author
-
Nikonov, Oleg, Kravchenko, Olesya, Nevskaya, Natalia, Stolboushkina, Elena, Garber, Maria, and Nikonov, Stanislav
- Subjects
- *
PROTHROMBIN , *RIBOSOMES , *MAGNESIUM ions , *HYDROLYSIS , *UNIT cell , *MOLECULES - Abstract
The structure of the γ subunit of archaeal translation initiation factor 2 (aIF2) from Sulfolobus solfataricus (SsoIF2γ) was determined in complex with GDPCP (a GTP analog). Crystals were obtained in the absence of magnesium ions in the crystallization solution. They belonged to space group P1, with five molecules in the unit cell. Four of these molecules are related in pairs by a common noncrystallographic twofold symmetry axis, while the fifth has no symmetry equivalent. Analysis of the structure and its comparison with other known aIF2 γ‐subunit structures in the GTP‐bound state show that (i) the magnesium ion is necessary for the formation and the maintenance of the active form of SsoIF2γ and (ii) in addition to the two previously known structural switches 1 and 2, eukaryotic translation initiation factor 2 (eIF2) and aIF2 molecules have another flexible region (switch 3), the function of which may consist of initiation of the hydrolysis of GTP and the removal of e/aIF2 from the ribosome after codon–anticodon recognition. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. The Cellular Response to Unfolded Proteins in the Endoplasmic Reticulum
- Author
-
Kaufman, Randal J., Scheuner, Donalyn, Tirasophon, Witoon, Yin-Liu, Chuan, Song, Benbo, Lee, Kuei C., McEwen, Edward, Weir, Susan-Bonner, Merten, O.-W., editor, Mattanovich, D., editor, Lang, C., editor, Larsson, G., editor, Neubauer, P., editor, Porro, D., editor, Postma, P., editor, de Mattos, J. Teixeira, editor, and Cole, J. A., editor
- Published
- 2001
- Full Text
- View/download PDF
4. Eukaryotic translation initiation factor 2 α phosphorylation as a therapeutic target in diabetes.
- Author
-
Yong, Jing, Grankvist, Nina, Han, Jaeseok, and Kaufman, Randal J
- Subjects
MESSENGER RNA ,GENETIC translation ,EUKARYOTES ,GENETIC transduction ,PROTEIN kinases - Abstract
Regulation of mRNA translation is of vital importance for a cell to adapt to environmental changes. To serve this purpose, intricate mechanisms controlling mRNA translation have evolved, of which the eukaryotic initiation factors eIF2 and eIF4 represent essential regulatory nodes for both stress sensing and signal transduction. Stress sensing by eIF2 α subunit (eIF2α) kinases, translation regulation by eIF2α subunit phosphorylation and subsequent dephosphorylation constitute a core molecular switch for stress adaptation and rapid metabolic regulation. It is not surprising; therefore, that dysfunction of such a pathway is implicated in human disease, especially metabolic syndrome and diabetes. In theory, therapeutic intervention to target the eIF2α phosphorylation pathway provides a promising therapeutic solution to tackle this debilitating syndrome. Careful evaluation of such therapies is crucially needed considering the central role of eIF2α pathway in cellular function for every organ. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. GTP-dependent Recognition of the Methionine Moiety on Initiator tRNA by Translation Factor eIF2
- Author
-
Kapp, Lee D. and Lorsch, Jon R.
- Subjects
- *
EUKARYOTIC cells , *G proteins , *PROTEIN synthesis , *RNA - Abstract
Eukaryotic translation initiation factor 2 (eIF2) is a G-protein that functions as a central switch in the initiation of protein synthesis. In its GTP-bound state it delivers the methionyl initiator tRNA (Met-tRNAi) to the small ribosomal subunit and releases it upon GTP hydrolysis following the recognition of the initiation codon. We have developed a complete thermodynamic framework for the assembly of the Saccharomyces cerevisiae eIF2·GTP·Met-tRNAi ternary complex and have determined the effect of the conversion of GTP to GDP on eIF2''s affinity for Met-tRNAi in solution. In its GTP-bound state the factor forms a positive interaction with the methionine moiety on Met-tRNAi that is disrupted when GTP is replaced with GDP, while contacts between the factor and the body of the tRNA remain intact. This positive interaction with the methionine residue on the tRNA may serve to ensure that only charged initiator tRNA enters the initiation pathway. The toggling on and off of the factor''s interaction with the methionine residue is likely to play an important role in the mechanism of initiator tRNA release upon initiation codon recognition. In addition, we show that the conserved base-pair A1:U72, which is known to be a critical identity element distinguishing initiator from elongator methionyl tRNA, is required for recognition of the methionine moiety by eIF2. Our data suggest that a role of this base-pair is to orient the methionine moiety on the initiator tRNA in its recognition pocket on eIF2. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
6. The double-stranded RNA-activated protein kinase mediates viral-induced encephalitis
- Author
-
Scheuner, Donalyn, Gromeier, Matthias, Davies, Monique V., Dorner, Andrew J., Song, Benbo, Patel, Rupali V., Wimmer, Eckard J., McLendon, Roger E., and Kaufman, Randal J.
- Subjects
- *
PROTEIN kinases , *VIRUS diseases , *HISTOPATHOLOGY , *TRANSGENIC mice - Abstract
The double-stranded (ds) RNA-activated protein kinase (PKR) plays an important role in control of viral infections and cell growth. We have studied the role of PKR in viral infection in mice that are defective in the PKR signaling pathway. Transgenic mice were derived that constitutively express a trans-dominant-negative kinase-defective mutant PKR under control of the β-actin promoter. The trans-dominant-negative PKR mutant expressing transgenic mice do not have a detectable phenotype, similar to observations with PKR knock-out mice. The requirement for PKR in viral pathogenesis was studied by intracerebral infection of mice with a mouse-adapted poliovirus. Histopathological analysis revealed diffuse encephalomyelitis with severe inflammatory lesions throughout the central nervous system (CNS) in infected wild-type mice. In contrast, histopathological evaluation of virus-injected trans-dominant-negative PKR transgenic mice as well as PKR knock-out mice yielded no signs of tissue damage associated with inflammatory host responses. However, the virus did replicate in both models of PKR-deficient mice at a level equal to that observed in wild-type infected mice. Although the results indicate a clear difference in susceptibility to poliovirus-induced encephalitis, this difference manifests clinically as a slight delay in fatal neuropathy in trans-dominant-negative PKR transgenic and PKR knock-out animals. Our observations support the finding that viral-induced PKR activation may play a significant role in pathogenesis by mediating the host response to viral CNS infection. They support PKR to be an effective target to control tissue damage due to deleterious host responses to viral infection. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
7. Identification of mitochondrial dysfunction in Hutchinson–Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture
- Author
-
Pablo Cabezas-Sanchez, Jose L. Luque-Garcia, José Antonio Enríquez, Diego Megias, Carlos López-Otín, Fernando G. Osorio, Vicente Andrés, José Rivera-Torres, Carmen Cámara, Rebeca Acín-Pérez, Cristina González-Gómez, Ministerio de Economía y Competitividad (España), Instituto de Salud Carlos III, Progeria Research Foundation, Comunidad de Madrid (España), Ministerio de Educación (España), Fundación ProCNIC, and Fundación Cajastur
- Subjects
Male ,Proteomics ,Ribosomal protein S6 kinase, 70kDa, polypeptide 1 ,ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide ,ATP5B ,Molecular biology of aging ,ENO2 ,Pyruvate kinase, muscle ,ATP5F1 ,Zoledronic Acid ,SILAC ,Biochemistry ,Progerin ,LMNA ,Mice ,Adenosine Triphosphate ,Methionine ,Progeria ,cytochrome c oxidase ,Amino Acids ,Stable isotope labeling with amino acids in cell culture ,Child ,p70S6K ,Pravastatin ,Skin ,Mammalian target of rapamycin ,Diphosphonates ,integumentary system ,Imidazoles ,ATP5O ,Nuclear Proteins ,Lamin Type A ,MAF ,OXPHOS ,PKM ,Mitochondria ,Cell biology ,ATP5A1 ,FTI ,mTOR ,HGPS ,eIF2 ,Female ,eIF4 ,Flavoprotein subunit of succinate dehydrogenase ,CS ,Accelerated aging ,Premature aging ,Senescence ,congenital, hereditary, and neonatal diseases and abnormalities ,Adolescent ,Biophysics ,Mouse adult fibroblast ,ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide ,Biology ,ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit ,ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1 ,Oxygen Consumption ,Eukaryotic translation initiation factor 2 ,Zinc metalloproteinase STE24 homolog ,Eukaryotic translation initiation factor 4 ,ATP5C1 ,medicine ,Animals ,Humans ,Zmpste24 ,Oxidative phosphorylation ,Protein Precursors ,Hutchinson–Gilford progeria syndrome ,Enolase 2 ,COX ,Galactose ,nutritional and metabolic diseases ,Fibroblasts ,medicine.disease ,Molecular biology ,Glucose ,ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 ,Farnesyltransferase inhibitor ,Gene Expression Regulation ,Mutation ,Lamin A ,FpSDH ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Mitochondrial dysfunction ,citrate synthase - Abstract
UNLABELLED: Hutchinson-Gilford progeria syndrome (HGPS) is a rare segmental premature aging disorder that recapitulates some biological and physical aspects of physiological aging. The disease is caused by a sporadic dominant mutation in the LMNA gene that leads to the expression of progerin, a mutant form of lamin A that lacks 50 amino acids and retains a toxic farnesyl modification in its carboxy-terminus. However, the mechanisms underlying cellular damage and senescence and accelerated aging in HGPS are incompletely understood. Here, we analyzed fibroblasts from healthy subjects and HGPS patients using SILAC (stable isotope labeling with amino acids in cell culture). We found in HGPS cells a marked downregulation of mitochondrial oxidative phosphorylation proteins accompanied by mitochondrial dysfunction, a process thought to provoke broad organ decline during normal aging. We also found mitochondrial dysfunction in fibroblasts from adult progeroid mice expressing progerin (Lmna(G609G/G609G) knock-in mice) or prelamin A (Zmpste24-null mice). Analysis of tissues from these mouse models revealed that the damaging effect of these proteins on mitochondrial function is time- and dose-dependent. Mitochondrial alterations were not observed in the brain, a tissue with extremely low progerin expression that seems to be unaffected in HGPS. Remarkably, mitochondrial function was restored in progeroid mouse fibroblasts treated with the isoprenylation inhibitors FTI-277 or pravastatin plus zoledronate, which are being tested in HGPS clinical trials. Our results suggest that mitochondrial dysfunction contributes to premature organ decline and aging in HGPS. Beyond its effects on progeria, prelamin A and progerin may also contribute to mitochondrial dysfunction and organ damage during normal aging, since these proteins are expressed in cells and tissues from non-HGPS individuals, most prominently at advanced ages. BIOLOGICAL SIGNIFICANCE: Mutations in LMNA or defective processing of prelamin A causes premature aging disorders, including Hutchinson-Gilford progeria syndrome (HGPS). Most HGPS patients carry in heterozygosis a de-novo point mutation (c.1824C>T: GGC>GGT; p.G608G) which causes the expression of the lamin A mutant protein called progerin. Despite the importance of progerin and prelamin A in accelerated aging, the underlying molecular mechanisms remain largely unknown. To tackle this question, we compared the proteome of skin-derived dermal fibroblast from HGPS patients and age-matched controls using quantitative stable isotope labeling with amino acids in cell culture (SILAC). Our results show a pronounced down-regulation of several components of the mitochondrial ATPase complex accompanied by up-regulation of some glycolytic enzymes. Accordingly, functional studies demonstrated mitochondrial dysfunction in HGPS fibroblasts. Moreover, our expression and functional studies using cellular and animal models confirmed that mitochondrial dysfunction is a feature of progeria which develops in a time- and dose-dependent manner. Finally, we demonstrate improved mitochondrial function in progeroid mouse cells treated with a combination of statins and aminobisphosphonates, two drugs that are being evaluated in ongoing HGPS clinical trials. Although further studies are needed to unravel the mechanisms through which progerin and prelamin A provoke mitochondrial abnormalities, our findings may pave the way to improved treatments of HGPS. These studies may also improve our knowledge of the mechanisms leading to mitochondrial dysfunction during normal aging, since both progerin and prelamin A have been found to accumulate during normal aging. Work in the author's laboratories is supported by grants from the Spanish Ministry of Economy and Competiveness (MINECO) (SAF2010-16044; SAF2011-23089, SAF2009-08007, CSD2007-00020, CTQ2010-18644), Instituto de Salud Carlos III (ISCIII) (RD06/0014/ 0021, RD12/0042/0028), the Progeria Research Foundation (Innovator Award PRF 2012-42), and Comunidad de Madrid (S2011/BMD-2402). P.C.-S. was financially supported by an FPU scholarship from the Spanish Ministry of Education. The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by MINECO and Pro-CNIC Foundation, and the Instituto Universitario de Oncología by Obra Social Cajastur. Sí
- Published
- 2013
- Full Text
- View/download PDF
8. Localization and function of a eukaryotic-initiation-factor-2-associated 67-kDa glycoprotein.
- Author
-
Wu S
- Abstract
Aim: To study the localization and function of a eukaryotic initiation factor 2 (eIF2α)-associated 67-kDa glycoprotein (p67)., Methods: Immunofluorescence staining, (35)S-Met/Cys metabolic labeling, Western blotting analysis, sucrose gradient centrifugation and high speed centrifugation were used to determine the localization of proteins in transiently transfected COS-1 cells. Transient co-transfection followed by co-immunoprecipitation was used to study the interaction between p67 and double-stranded RNA (dsRNA)-dependent protein kinase (PKR). Wheat germ agglutinin agarose beads were used to absorb glycosylated proteins. In vivo(32)P-labeling followed by immunoprecipitation and Western blotting were used to measure PKR autophosphorylation, eIF2α phosphorylation, and p67 expression in normal and breast cancer cells., Results: The image from immunofluorescence staining showed that p67 was overexpressed in the cytosol but not in the nucleus. In a sucrose gradient, approximately 30% of the overexpressed p67 was bound with ribosomes. p67 interacted with the kinase domain, but not the dsRNA-binding domains of PKR. Only the glycosylated p67 was associated with the ribosome, and p67 did not compete with PKR for ribosome binding. In breast cancer cells, there was increased autophosphorylation of PKR but no phosphorylation of eIF2α, compared with normal breast cells.α The ratio of glycosylated/deglycosylated p67 was altered in breast cancer cells., Conclusion: Glycosylation of p67 is required for its ribosomal association and can potentially inhibit PKR via interaction with the kinase domain of PKR.
- Published
- 2010
- Full Text
- View/download PDF
9. Roles of a 67-kDa Polypeptide in Reversal of Protein Synthesis Inhibition in Heme-Deficient Reticulocyte Lysate
- Author
-
Datta, Bansidhar, Chakrabarti, Debopam, Roy, Ananda L., and Gupta, Naba K.
- Published
- 1988
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.